Loading this company
Loading this company
Priced above our range of $80.18 to $187.99.
$255.56USD up +$2.28 (+0.90%)
Quoted · Prices are delayed.
Nothing we can cite explains today’s move for this company.
Our range from 4 models, on today’s numbers
$80.18–$187.99
What the price needs: revenue growth of 14.9%/yr for 5 years (our model assumes 5.3%).
Led by discounted cash flow (DCF) · Dividend income business
Price $255.56Priced · Prices are delayed.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
$279.41 across 22 analysts
The high and low of the analyst range is part of Pro. See plans
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. It operates in the Drug Manufacturers - General industry (Healthcare sector), headquartered in United States. The company employs roughly 138,200 people.
Prices are delayed. The feed does not say when these figures were taken.
No recent headlines we can cite for this company.
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.